Literature DB >> 18301501

Investigation of the polarization optics of the living human cornea and lens with purkinje images.

B K Pierscionek, R A Weale.   

Abstract

We present what to our knowledge is a new method for assessing the polarization optics of the cornea and lens, by examining the state of polarization of the first, second, and fourth Purkinje images. When linearly polarized light is incident on the cornea at 70 degrees to the line of gaze along the horizontal meridian, and then traverses the cornea, or the cornea and the lens, the emergent light is elliptically polarized. The degree of ellipticity varies widely between subjects. The results indicate that both the cornea and the lens may be optically active and to our knowledge are the first to suggest that the cornea may exhibit circular birefringence.

Entities:  

Year:  1998        PMID: 18301501     DOI: 10.1364/ao.37.006845

Source DB:  PubMed          Journal:  Appl Opt        ISSN: 1559-128X            Impact factor:   1.980


  4 in total

1.  Improved contrast of subretinal structures using polarization analysis.

Authors:  Stephen A Burns; Ann E Elsner; Mariane B Mellem-Kairala; Ruthanne B Simmons
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

2.  Corneal birefringence measured by spectrally resolved Mueller matrix ellipsometry and implications for non-invasive glucose monitoring.

Authors:  Peter Westphal; Johannes-Maria Kaltenbach; Kai Wicker
Journal:  Biomed Opt Express       Date:  2016-03-07       Impact factor: 3.732

3.  Imaging shear stress distribution and evaluating the stress concentration factor of the human eye.

Authors:  S Joseph Antony
Journal:  Sci Rep       Date:  2015-03-10       Impact factor: 4.379

4.  Interference figures of polarimetric interferometry analysis of the human corneal stroma.

Authors:  Rodolfo Mastropasqua; Mario Nubile; Niccolò Salgari; Manuela Lanzini; Roberta Calienno; Peter A Mattei; Alessandra Sborgia; Luca Agnifili
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.